1035.4000 0.90 (0.09%)
NSE Sep 17, 2025 14:30 PM
Volume: 549.0K
 

1035.40
0.09%
Axis Direct
Cadila's (CDH) Q4 revenue at Rs 25.2 bn (up 6% YoY) and EBITDA at Rs 4.6 bn (down 16% YoY) were in line with estimates. PAT at Rs 3.85 bn was aided by higher other income and lower tax expense.
Zydus Lifesciences Ltd. is trading above all available SMAs
More from Zydus Lifesciences Ltd.
Recommended